European Union Approves New Vaccine for Ebola

Submitted by [email protected] on Mon, 06/01/2020 - 12:00 PM


The European Union approved a new vaccine to prevent Ebola virus disease (Zaire ebolavirus species) in individuals aged 1 year and older.  The vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.

Content Source: European Union European Medicines Agency

Content Author: European Union European Medicines Agency